Paraprotein Sample Exchange in Australia and New Zealand - 2018

Area of Science:

• Clinical Chemistry
• Immunology
• Laboratory Medicine

Background:

• Accurate quantification of paraproteins in the beta-region is crucial for monitoring plasma cell dyscrasias.
• Inter-laboratory variation in reporting beta-migrating paraproteins can affect patient management and care.
• Serum protein electrophoresis (SPE) is a key diagnostic tool, but challenges exist in standardizing results.

Purpose of the Study:

• To assess the practical difficulties and extent of agreement in reporting beta-migrating paraproteins.
• To identify variations in quantification and reporting across laboratories in Australia and New Zealand.
• To evaluate the potential impact of these variations on patient monitoring and management.

Main Methods:

• A multi-center study involving sample exchanges was conducted across five Australian states and New Zealand.
• Laboratories performed serum protein electrophoresis and reported on beta-migrating paraproteins.
• Data on quantification and reporting practices were collected and analyzed.

Main Results:

• Significant variation was observed in the quantification of co-migrating paraproteins in the beta-region.
• Discrepancies in reporting practices were identified between participating laboratories.
• The study highlighted practical difficulties encountered by laboratories in this specific assay.

Conclusions:

• There is a notable variation in the quantification and reporting of beta-migrating paraproteins.
• This variability poses a potential risk to consistent patient monitoring and management during plasma cell dyscrasia surveillance.
• Standardization of methods and reporting for beta-migrating paraproteins is warranted to improve diagnostic accuracy and patient care.